Enzyme Inhibition and Induction in Liver Disease

By  

Current Clinical Pharmacology, Vol. 3, Iss. 1, 2008-01 ,pp. : 56-69

Bentham Science Publishers

Access to resources Recommend Favorite

Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies

By Hewitt Nicola   Lechón María José Gómez   Houston J. Brian   Hallifax David   Brown Hayley   Maurel Patrick   Kenna J. Gerald   Gustavsson Lena   Lohmann Christina   Skonberg Christian   Guillouzo Andre   Tuschl Gregor   Li Albert   LeCluyse Edward   Groothuis Geny   Hengstler Jan  

Drug Metabolism Reviews, Vol. 39, Iss. 1, 2007-01 ,pp. : 159-234

Informa Healthcare

Access to resources Recommend Favorite

Enzyme Inhibition

By  

Current Bioactive Compounds, Vol. 3, Iss. 4, 2007-12 ,pp. : 310-311

Bentham Science Publishers

Access to resources Recommend Favorite

Xanthine Oxidase and its Role as Target in Cardiovascular Disease: Cardiovascular Protection by Enzyme Inhibition?

By  

Current Pharmaceutical Design, Vol. 23, Iss. 23, 2017-09 ,pp. : 3391-3404

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Metabolism in Parathion-Induced Hepatotoxicity and Immunotoxicity

By Ok Kim Dae   Kyu Lee Sang   Won Jeon Tae   Hua Jin Chun   Hee Hyun Sun   Jung Kim Eun   Im Moon Gui   Kim Jung-Ae   Seok Lee Eung   Mu Lee Byung   Gwang Jeong Hye   Cheon Jeong Tae  

Journal of Toxicology and Environmental Health, Vol. 68, Iss. 23-24, 2005-12 ,pp. : 2187-2205

Taylor & Francis Ltd

Access to resources Recommend Favorite